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Introduction 
Encephalitis with Anti-NMDA receptor (NMDAr) antibodies is a recently described, subacute 
severe condition occurring mostly in young women. Its course typically presents with initially 
prominent psychiatric symptoms followed by seizures, movement disorders, and eventually 
consciousness impairment, as well as dysautonomia1. The predominance of psychiatric 
symptoms observed at onset can render the identification of the condition challenging. 
Identification of anti-NMDA receptor antibodies in the cerebrospinal fluid (CSF) and serum is 
diagnostic. As a proportion of cases are paraneoplastic, 18F-fluorodeoxyglucose (FDG) 
positron emission tomography (PET) of the body is used to screen potential neoplasia in 
patients. Several reports showed a characteristic cerebral FDG-PET pattern in this condition, 
with a rostral cortical hypermetabolism as compared to posterior regions2.  Clinically, 
movement disorders1 also suggest involvement of subcortical structures, which has been 
demonstrated in MRI3.  
The determination of specific cerebral metabolic changes translating into FDG uptake could 
provide an additional diagnostic tool alongside the auto-antibodies level to help early 
diagnosis and monitor disease activity. 
 
Methods 
We retrospectively reviewed the brain FDG PET results of 5 episodes of anti-NMDAr 
encephalitis in 4 patients. All PET were performed as part of the clinical work-up. To 
ascertain that the exam was performed interictally, all scans were performed under EEG 
monitoring beginning 20 minutes before the intravenous injection of 150 to 250 MBq of 18F-
FDG, until 20 minutes thereafter. A 20-minute 3D PET image of the brain was acquired 
(Discovery 690 VCT, GE Healthcare, Waukesha, Wisconsin, USA). All patients had a brain MRI 
as part of the clinical evaluation; T1 weighted images were fused to the FDG PET using the 
PMOD Software (version 3.403, PMOD Technologies Ltd., Zurich, Switzerland). MRI images 
were used to fit a 67 voxels of interest model to individual anatomical features for which 
FDG uptake was measured. The patient group was compared to 10 controls of 
the same mean age from a database of 25 healthy probands4 . The healthy subjects were 
processed the same way using the PMOD software, and a voxel based group 
comparison was performed using SPM8 (P-value < 0.001, corrected for the cluster). 
 
Results 
The details of the 5 episodes (4 patients, 1 relapse) are summarised in Figure 1a. Figure 1b 
shows the comparison of FDG uptake in patients versus healthy probands, where the cortical 
anteroposterior gradient and an increased uptake in the striatum are seen. Figure 1c shows 
the FDG uptake ratio, normalized to global uptake, in the caudate nuclei, the occipital, 
parietal and frontal cortex, using cerebellar vermis as normalisation reference, highlighting 
statistical differences. 
 
Discussion 
This series confirms the cortical anterior-posterior decreasing FDG uptake gradient outlined 
in patients with NMDAr encephalitis 2, 5. However, the majority of reports did not describe 
subcortical structures: our study pooling 5 episodes matched with healthy controls clearly 
shows selective, bilateral striatal hypermetabolism. Abnormalities in striatum have been 
previously described in structural imaging 5:  caudate nuclei diffusion alterations in MRI were 
shown in a patient with strikingly prominent dystonia6 and in another case with transient 
hypoxemia3.  
 
This metabolic pattern seems to be consistent throughout the course of the disease, as it 
was found in all cases at varying delay from the onset of the disease, and appears also to be 
independent of the concomitant EEG overall activity or the administered sedation. There are 
suggestions that the intensity of the PET abnormalities correlates with the severity of the 
disease at least within the course of a single episode5, 7. This may render FDG-PET a useful 
addition to the diagnostic of relapses. Anti-NMDAr antibodies may indeed not normalise 
between relapses, their detection alone being therefore potentially not sufficient to 
conclude to a relapse in the presence of dubious symptoms. It is moreover not uncommon 
for patients who recovered from a first episode of encephalitis not to undergo another 
lumbar puncture to assess the normalisation of the autoantibodies. In our series, the FDG-
PET abnormal pattern was found already 2 weeks in the course of a relapse with only mild 
psychiatric symptoms (episode 1), suggesting indeed that PET abnormalities can prove 
clinically useful when assessing people with suspected anti-NMDAr encephalitis.  
 
Although this pattern appears to be highly suggestive of NMDAr encephalitis, some cases 
showing different abnormalities such as lateralised/focal areas of hyper- or hypometabolism 
were also reported7. This discrepancy seems not to be explained by parenchymal lesions in 
cases with focal alteration of metabolism. Further trials should be performed this population 
to first confirm our observations and precise the role of PET. 
 
 
 
 
 
 
Figure 1 Legend 
a. Clinical details of the episodes, episodes N= 1 and 2 occurred in the same patient. 
*Quantitative data were not available at the time of this episode. b. FDG uptake ratio in 
different regions in patients (dots) compared with healthy probands (bars show mean ± SD). 
c. SPM analysis of FDG uptake pattern showed on superimposed MRI, with red 
corresponding to hypermetabolism, and blue to hypometabolism compared to the healthy 
probands (FDG uptake normalized to the whole cortex; a normalization to the cerebellar 
vermis led to similar results). Please note that in this SPM voxel-based analysis, 
hypermetabolism of the striatum predominated in the putamen. 
 
References: 
1. Graus F, Saiz A, Lai M, et al. Neuronal surface antigen antibodies in limbic encephalitis: 
clinical-immunologic associations. Neurology 2008;71:930-936. 
2. Leypoldt F, Buchert R, Kleiter I, et al. Fluorodeoxyglucose positron emission tomography in 
anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg 
Psychiatry 2012;83:681-686. 
3. Gunther A, Brodoehl S, Witte OW, Freesmeyer M, Dalmau JO, Redecker C. Atypical 
posthypoxic MRI changes in hypermetabolic regions in anti-NMDA-receptor encephalitis. Neurology 
2012;79:720-721. 
4. Guedj E, Aubert S, McGonigal A, Mundler O, Bartolomei F. Deja-vu in temporal lobe epilepsy: 
metabolic pattern of cortical involvement in patients with normal brain MRI. Neuropsychologia 
2010;48:2174-2181. 
5. Maeder-Ingvar M, Prior JO, Irani SR, Rey V, Vincent A, Rossetti AO. FDG-PET hyperactivity in 
basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis. J Neurol 
Neurosurg Psychiatry 2011;82:235-236. 
6. Tzoulis C, Vedeler C, Haugen M, et al. Progressive striatal necrosis associated with anti-NMDA 
receptor antibodies. BMC Neurol 2013;13:55. 
7. Probasco JC, Benavides DR, Ciarallo A, et al. Electroencephalographic and 
fluorodeoxyglucose-positron emission tomography correlates in anti-N-methyl-d-aspartate receptor 
autoimmune encephalitis. Epilepsy & Behavior Case Reports 2014;2:174-178. 
 

